KELSEY WHIPPS: Open Payments
NPI 1962101618 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 42 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $587 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $159 |
| AstraZeneca Pharmaceuticals LP | 8 | $148 |
| Paratek Pharmaceuticals, Inc. | 4 | $141 |
| ABBVIE INC. | 3 | $86 |
| SHIELD THERAPEUTICS INC | 3 | $73 |
| Lilly USA, LLC | 3 | $68 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
| Optinose US, Inc. | 1 | $30 |
| Electromed, Inc. | 1 | $23 |
| Medtronic, Inc. | 1 | $19 |
Products named: NUZYRA, AIRSUPRA, Ozempic, ACCRUFER, MOUNJARO, QULIPTA, Wegovy, SPRAVATO.
Industry payments across OK — which companies pay providers there.
